Top Markets
#1 Pleasing Gold Pleasing Gold +1,502.41%
#2 PulseChain PulseChain +58.12%
#3 Merlin's Seal BTC Merlin's Seal BTC +33.03%
#4 BOOK OF MEME BOOK OF MEME +27.49%
#5 Ontology Gas Ontology Gas +27.07%
#6 Unit Pump Unit Pump +23.05%
#7 Pump.fun Pump.fun +23.05%
#8 Nockchain Nockchain +22.70%
#9 Neiro Neiro +22.35%
#10 ConstitutionDAO ConstitutionDAO +21.16%
Coin of the day
Pleasing Gold Pleasing Gold
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals, Inc.

Aerpio Pharmaceuticals, Inc.

ARPO
Classifica tra le azioni #26438
Aerpio Pharmaceuticals Inc., a biopharmaceutical enterprise headquartered in... Aerpio Pharmaceuticals Inc., a biopharmaceutical enterprise headquartered in Blue Ash, Ohio, currently employs 27 full-time staff. The company's core mission revolves around the research and development of therapeutic solutions for ocular diseases. Its product pipeline is spearheaded by AKB-9778, with two additional programs, AKB-4924 and ARP-1536, also under development. AKB-9778 is a small molecule designed to activate the Tie-2 pathway, intended for the treatment of diabetic retinopathy (DR). AKB-4924, another candidate, functions as a selective stabilizer of hypoxia-inducible factor-1 alpha (HIF-1alpha) and is being investigated for its potential in treating inflammatory bowel disease (IBD). ARP-1536 is a humanized monoclonal antibody that targets the same pathway as AKB-9778. It operates by attaching to the extracellular domain of vascular endothelial protein tyrosine phosphatase (VE-PTP), thereby inhibiting its interaction with Tie-2. As of April 14, 2017, Aerpio had successfully concluded a Phase II clinical trial for AKB-9778, which involved 144 patients with diabetic macular edema. By the same date, a Phase Ia clinical trial for AKB-4924 in healthy volunteers had also been completed.
Prezzo delle azioni
$2.20
Ultima sincronizzazione: 2021-08-26
Capitalizzazione di mercato
$40.53M
Variazione (1 giorno)
-0.90%
Variazione (1 anno)
0.00%
Paese
US
Scambia Aerpio Pharmaceuticals, Inc. (ARPO)

Categoria

Healthcare
Storico dividendi per Aerpio Pharmaceuticals, Inc. (ARPO)
Aerpio Pharmaceuticals, Inc. (simbolo azionario: ARPO) ha effettuato un totale di 0 pagamenti di dividendi.
La somma totale dei dividendi (rettificata per split azionari) è: 0.00
Rendimento da dividendo (TTM): 0
Pagamenti dei dividendi per Aerpio Pharmaceuticals, Inc. (ARPO) dal 2026 al 2026
Pagamenti annuali dei dividendi
Anno Dividendo (rettificato per split azionari) Cambia
Non abbastanza dati per le date fornite.
Elenco di tutti i pagamenti di dividendi
Anno Dividendo Cambia
Non abbastanza dati per le date fornite.
Dividendi di aziende simili o concorrenti
Azienda Numero di pagamenti di dividendi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH